DBVT

DBV Technologies S.A. - ADR

12.26

USD

-0.38

-2.97%

Sep 23, 15:15 UTC -4

Open

DBV Technologies S.A. - ADR Profile

About

DBV Technologies SA is a biopharmaceutical company. It develops products and immunotherapies for the diagnosis and treatment of various food allergies, including milk and peanut. The Company delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin. DBV Technologies SA is headquartered in Bagneux, France.

Info & Links

CEO

Daniel Tass�

Headquarters

107 AVENUE DE LA REPUBLIQUE
CHATILLON, I0 92320, FRANCE

Auditor

Deloitte & Associ�s

Share holders

330

Employees

125

DBV Technologies S.A. - ADR Statistics

Valuation Measures

Market Capitalization²

770.21M

Enterprise Value

595.31M

Enterprise Value/EBITDA(ttm)

-3.41

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

151.59

Price to Book(mrq)

4.47

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-3506.53%

Profit Margin(ttm)

-5413.23%

Return on Equity(ttm)

-119.33%

Return on Invested Capital(ttm)

-143.59%

Return on Assets(ttm)

-84.43%

Income Statement

Revenue(ttm)

4.94M

Revenue Per Share(ttm)

0.08

Gross Profit(ttm)

4.94M

EBITDA(ttm)³

-174.76M

Net Income Available to Common(ttm)

-175.95M

Diluted EPS(ttm)

-3.51

Share Statistics

Beta (5Y Monthly)

-0.95

52-Week Change

29.00%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

59.21M

Dividend Yield

0.00%

Float⁴

62.21M

% Held by Insiders

1.06%

% Held by Institutions

71.74%

Balance Sheet

Total Cash(mrq)

174.90M

Total Cash Per Share(mrq)

2.95

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.72%

Quick Ratio(mrq)

3.72%

Book Value Per Share(mrq)

2.71

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.17

Free Cash Flow(ytd)

-102.50M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.